Standard Ferriscan growth was 14%. Nothing yet from Hepafat.
Overall, still growing reasonably but needs Hepafat and/or fibrosis scan to really take off. The 14% growth in Ferriscan is still consistent with a 7c SP on Ferriscan alone.
Good potential is still there assuming the new scans can start bringing in some revenue.
Ann: Preliminary Final Report, page-5
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RHT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $24.57M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200000 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 116743 | 2 |
View Market Depth
| Last trade - 16.12pm 12/07/2024 (20 minute delay) ? |
| RHT (ASX) Chart |
Day chart unavailable